Addex Therapeutics Ltd.
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Their pipeline includes compounds targeting post-stroke recovery, substance use disorder and chronic cough. The company utilizes its expertise in allosteric modulation for drug discovery.
Registro Oficial
Última verificación: 1/2/2026
Análisis de Calidad IA
Desglose de Puntuación de Confianza
Enlaces Rápidos
Destacados del sitio web
🌟 Empresas similares de confianza
Aquestive Therapeutics, Inc.
Aquestive is a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies. They develop orally administered products to deliver complex molecules, providing novel alternatives to invasive and inconvenient standard of care therapies. Aquestive has commercialized products marketed by its licensees and is the exclusive manufacturer of these licensed products.
SERVIER OUTRE-MER
Servier is an independent international pharmaceutical company focused on therapeutic progress for patients. They invest significantly in research and development, particularly in oncology, cardiometabolism, and neuroscience. Servier is known for its long-term vision and commitment to patients' needs.
AGILERA PHARMA AS
Agilera es una CDMO líder que contribuye al desarrollo tecnológico y al crecimiento en el mercado radiofarmacéutico. Ofrecen toda la cadena de valor para el desarrollo de nuevos radiofármacos, desde la fase preclínica hasta la producción comercial y la distribución global. Agilera está aprobada como fabricante para EE. UU., Japón, Europa, Latinoamérica y China.